Congenital recessive ichthyoses represent a vast and markedly heterogeneous group of diseases that have been mapped to at least seven distinct chromosomal loci. In this study, we ascertained two consanguineous families presenting with congenital ichthyosis. Using homozygosity mapping, we identified a 6.5 cM homozygous region on 12p11.2-q13 shared by all affected individuals. Multipoint logarithm of odds ratio (LOD) score analysis placed the new locus between markers D12S345 and D12S390 with a maximum LOD score of 4.79 at marker CH12SSR13. This region harbors PPHLN1, encoding periphilin 1, a protein involved in the cornification process. No deleterious mutations were identified within the coding region of this gene, suggesting the existence of another gene associated with epidermal differentiation on 12p11.2-q13.
The recent years have witnessed spectacular advances in our understanding of disorders of cornification (Irvine and Paller, 2002) . Mutations in genes encoding numerous proteins involved in the process of keratinization have been shown to cause a spectrum of inherited skin disorders, among which the ichthyoses, a clinically and genetically heterogeneous group of genodermatoses, rank first in severity and prevalence (Irvine and Paller, 2002) . These disorders are often associated with defective skin barrier function, which can result in fluid and electrolyte imbalance, as well as life-threatening infections.
Ichthyoses are usually classified based on inheritance pattern, morphology and distribution of the scales, histological findings, and associated features. Congenital recessive ichthyoses (CRI) can be divided into non-syndromic and syndromic forms. The latter group includes numerous complex disorders such as Sjogren-Larsson syndrome (MIM270200) resulting from mutations in the fatty aldehyde dehydrogenase gene (De Laurenzi et al, 1996) , ChanarinDorfman syndrome (MIM275630), a neutral lipid storage disease caused by mutations in CGI-58 (Lefevre et al, 2001) , and Netherton syndrome (MIM256500) characterized by congenital ichthyosis, elevated levels of IgE, and hair structural anomalies, which results from mutations in SPINK5, encoding a serine protease inhibitor (Chavanas et al, 2000) . The clinical spectrum of non-syndromic CRI includes severe, classic lamellar ichthyosis (LI1 MIM242300, LI2 MIM601277, LI3 MIM604777, LI5 MIM606545) characterized by collodion membrane presentation (neonates born with a shiny and transparent cover that dries to thick, hard skin, then cracks, and fissures), development of large, plate-like scales, ectropion (turning out of eyelids), eclabium (turning out of the lips) but no erythema (Williams and Elias, 1985) . A second distinct subtype of CRI is congenital ichthyosiform erythroderma (CIE; MIM242100). The presence of an intense, generalized erythema and fine, white scales define this disease (Akiyama et al, 2003) . Patients may also manifest as collodion baby, and may have decreased sweating with severe heat intolerance. About 30% of all patients with CRI have mutations in the gene TGM1 on chromosome 14q (Russel et al, 1995; Laiho et al, 1997) . This gene encodes the enzyme transglutaminase-1, which catalyzes the transamidation of glutamine residues during the cross-linking of the cornified envelope proteins (Ishida-Yamamoto and Izuka, 2002) . CRI has also been shown to be caused by mutations in genes encoding lipoxygenase-3 and 12(R)-lipoxygenase (ALOXE3, ALOX12B) on 17p13.1 , the ATP-binding cassette (ABC)A12 transporter on 2q (Lefevre et al, 2003) , and ichthyin on 5q33 (Lefevre, 2004) . Other CRI cases have been mapped to 12q13 and 19p13.1-13.2 (Fischer et al, 2000; Virolainene et al; Hatsell et al, 2003) , but the causative genes associated with these loci remain to be uncovered. Moreover, further, so far unknown loci for CRI must exist (Krebsova et al, 2001 ) demonstrating extensive genetic heterogeneity in CRI.
Although no formal epidemiological study of recessive ichthyoses has been performed in the Middle East, they are estimated to be extremely frequent in this region because of a high rate of consanguineous unions (Zlotogora, 1997 this study, we mapped CRI to 12p11.2-q13 in two Israeli consanguineous families.
Results
Clinical findings We ascertained two Israeli families of Arab Moslem origin comprising 14 individuals, including five patients. In both families, parents were first-degree cousins. All five patients were born with normal-looking skin. No collodion membrane was noticed at birth. A few days after birth, fine whitish scales appeared.
The three patients in family 1 developed typical CIE features during childhood including severe erythroderma associated with generalized fine scaling. The erythroderma partly receded with age, but larger scales appeared and persisted through the years (Fig 1a) . Palmoplantar keratoderma manifested in all three patients with skin thickening and fissuring (Fig 1b) . A skin biopsy revealed epidermal compact hyperkeratosis, hypergranulosis, acanthosis, and papillomatosis. Over the years, the patients required repeated antifungal and antibiotic treatment courses because of tinea pedis, onychomycosis, and recalcitrant malodorous secondary bacterial infections. Patients 63 and 64 in family 1 received acitretin (50 mg per d) at the age of 35 and 30 y, respectively, for prolonged periods (1-2 y) with marked improvement.
In contrast with the early features of CIE manifested by family 1 patients, the two affected individuals of family 2 displayed only mild fine generalized scaling with minimal palmoplantar skin thickening (Fig 1c) . They were treated satisfactorily with skin moisturizers and emollients only.
In both families, growth and psychomotor development had been normal. No other diseases or abnormal laboratory findings were reported.
Identification of a new locus associated with CRI In both families, we initially ruled out linkage to seven known CRI-associated loci on 2q33-p35, 3p21, 12q11-q13, 14q11.2, 17p13. 2-13.1, 19p12-q12, 19p13 .2-13.1 (not shown). Based upon the fact that the families were consanguineous, we assumed the existence in each family of a homozygous causative mutation. Using a panel of fluorescently labeled markers, we genotyped the three patients of family 1 at 304 microsatellite loci, and scrutinized our results for regions of homozygosity shared by all three affected individuals. We identified such a region between markers D12S85 and D12S345 (not shown).
Because of the very low numbers of informative microsatellite markers available in this region in public databases, we characterized 15 novel markers within the suspected disease interval, six of which were found to be informative in our two families (Table I) . Using these and five additional markers derived from the NCBI Mapviewer database (http:// www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606) and spanning 19.9 cM on 12p11.2-q13, we genotyped all members of families 1 and 2. Multipoint logarithm of odds ratio (LOD) score analysis using the Superlink software for eight markers placed the new CRI-associated locus between markers D12S345 and D12S390 with a maximum LOD score of 4.79 at marker CH12SSR13 (Fig 2) . Multipoint LOD score analysis performed separately for each of the two families revealed a positive LOD score of 2.88 for family 1 and 1.91 for family 2. Similar results were obtained using the HOMOZ software, which generated a maximum combined LOD score of 4.05 at marker CH12SSR13.
We established parsimonious haplotypes for each individual (Fig 3) . Haplotype analysis revealed critical recombination events in individuals 68 and 65 at markers D12S1648 and D12S85, respectively, therefore defining the upper and lower boundaries of the disease interval in this family. Novel microsatellite markers were deposited in GenBank under accession numbers BV210260 (CH12SSR1), BV210261 (CH12SSR4), BV10262 (CH12SSR9), BV10263 (CH12SSR13), BV10264 (CH12SSR14), BV210265 (CH12SSR15). All markers are dinucleotide repeats except for CH12SSR13, which is a tetranucleotide repeat.
Haplotype analysis in family 2 did not help reduce the interval defined by analysis of family 1, since patients in this family were found to share a homozygous haplotype spanning more than 12 cM. The disease-associated region was found to span less than 6.5 cM. This novel locus is located 5 cM centromeric to the locus previously described by Hatsell et al (2003) .
Candidate gene analysis Using MapViewer (http:// www.ncbi.nlm.nih.gov/mapview/), we ascertained the disease interval. A total of 73 genes were identified within this interval (Fig 4) . Forty-seven genes are predicted open reading frames of unknown significance. Twenty-six genes have a known function, among which PPHLN1, encoding periphilin1, was considered as a prime candidate. Periphilin 1 is one of several proteins that become sequentially incorporated into the cornified cell envelope during the terminal differentiation of keratinocytes at the outer layers of the epidermis (Kazerounian and Aho, 2003) .
We developed primer pairs and established PCR conditions to amplify all exons and exon-intron boundaries of the PPHLN1 gene (Table II) . Genomic DNA obtained from one affected child of family 1 and one affected child from family 2 was assessed for sequence alterations in PPHLN1. No pathogenic mutation was found in PPHLN1 in both patients. To examine the possibility that a mutation located within a non-coding region may influence the gene expression, we extracted RNA from a skin biopsy obtained from patient 63 of family 1. We used RT-PCR to assess the gene expression in patient versus control skin. No evidence of reduced PPHLN1 expression in the patient's skin was observed in comparison with normal skin (not shown). These results suggest the existence of a gene associated with CRI on 12p11.2-q13 that is distinct from PPHLN1.
Discussion
In this study, we describe a novel chromosomal locus linked to CRI in two consanguineous families. This locus is the eight CRI-associated locus reported in recent years and adds to the steadily growing body of evidence pointing to extensive genetic heterogeneity in recessive ichthyoses (Krebsova et al, 2001; DiGiovanna et al, 2003) .
The 12p11.2-q13 locus was found to be centromeric to a neighboring locus on 12q11-q13 previously described in another consanguineous Israeli family of Bedouin origin (Hatsell et al, 2003) . Of note is the fact that in this study (Hatsell et al, 2003) , the mother of the family was homozygous for a series of markers encompassing the disease-critical interval, so that a recombination event within this region could not be totally excluded. Interestingly, none of nine other consanguineous CRI Israeli families that we recently assessed mapped to the 12q11-q13 or to the 12p11.2-q13 loci (not shown). These families displayed a more severe phenotype than the two families described in the present report.
Because of their relatively small size, LOD score calculated separately for each of the two families did not reach a value greater than 3. Although locus heterogeneity cannot be absolutely ruled out, the very large size of the interval shared by family 2 patients and the fact that family 1 patients did not display homozygosity for any other chromosomal region when screened with markers encompassing the whole genome do not support this possibility.
The disease interval shared by the two families described in this study harbors 73 genes. Among these, PPHLN1 was considered as a good candidate because periphilin 1 plays a role during the maturation of the cornified cell envelope, a major step during normal epidermal differentiation and barrier formation (Kazerounian and Aho, 2003) . Periphilin 1 is found in vitro in the nucleus of undifferentiated keratinocytes but at the cell periphery in differentiated keratinocytes, colocalizing there with periplakin (Kazerounian and Aho, 2003) . Alternative splicing of 5 0 -exons 2, 4, and 7 and 3 0 -exons 11-14, gives rise to multiple protein products. The exclusion of exon 2 deletes the first in-frame translation initiation codon. The second in-frame ATG encodes Met-8. No pathogenic mutations were, however, identified in all potential coding regions of the gene in our study. Other candidates present within the disease interval and deserving further scrutiny include ADAMTS20, a disintegrin-like metalloprotease (Somerville et al, 2003) and TMEM16F, a transmembrane protein (Katoh and Katoh, 2004) , presenting structural but no sequence similarity to other transmembranal proteins previously found to be involved in the pathogenesis of CRI (Lefevre et al, 2004) . ABCD2, also present within the disease interval, is a member of the ABC transporter family. Another member of this protein family has been implicated in the pathogenesis of CRI (Lefevre et al, 2003) . ABCD2, however, is speculated to function as a dimerization partner of ABCD1 and other peroxisomal ABC transporters, and is thought to play a role in the pathogenesis of adrenoleukodystrophy (Liu et al, 1999) . Expression and mutation analysis of these and other candidate genes within the disease interval as well as fur- ther reduction of the disease interval through assessment of additional families should lead to the identification of a novel gene coding for a protein of importance in the maintenance of proper epidermal differentiation.
Materials and Methods
Patients and biological materials All participants or their legal guardians provided written and informed consent according to a protocol previously approved by the local Helsinki Committee and by the Committee for Genetic Studies of the Israeli Ministry of Health. Blood samples were drawn from all family members, and DNA was extracted according to standard procedures.
Genotyping Genomic DNA was PCR amplified using either fluorescently labeled primer pairs (Research Genetics, Invitrogen, Carlsbad, California) or non-labeled primer pairs encompassing 26 chromosomal microsatellite repeats (Table I) . PCR conditions were: 951C for 4 min followed by 35 cycles at 951C for 30 s, 551C for 30 s (when not otherwise specified in Table  I ), 721C for 30 s, and a final extension step at 721C for 5 min. For semi-automated genotyping, PCR products were separated by PAGE on an ABI 310 sequencer system, and allele sizes were determined with Genescan 3.1 and Genotyper 2.0 software (PE Applied Biosystems, Foster City, California). For manual genotyping, amplicons were electrophoresed on 6% acrylamide gels followed by silver staining as previously described (Merril, 1986) .
PPHLN1 gene analysis Genomic DNA was PCR amplified using primer pairs encompassing all exons and exon-intron boundaries of the PPHLN1 gene (Table II) . Cycling conditions were 951C for 5 min followed by 35 cycles at 951C for 30 s, 571C-601C for 45 s, 721C for 90 s, and a final extension step at 721C for 7 min. Resulting amplicons were gel-purified (QIAquick gel extraction kit, Qiagen, Valencia, California) and subjected to bi-directional DNA sequencing using the BigDye terminator system on an ABI Prism 3100 sequencer (PE Applied Biosystems). 
MIZRACHI-KOREN ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
For RT-PCR, total RNA was extracted from a snap-frozen skin biopsy obtained from non-lesional skin using the RNeasy extraction kit (Qiagen) and amplified using the TITAN One Tube RT-PCR kit (Roche Molecular Biochemicals, Mannheim, Germany) and intron-crossing primer pairs specific for PPHLN1 located in exon 3 and 5, respectively (forward 5 0 -CATTTAGCTCATTCGATTAAG-3 0 and reverse 5 0 -CACATGAGAGCATCAAGCAG-3 0 ). PCR conditions were: 30 min at 501C; 941C for 2 min; 941C for 30 s, 601C for 30 s, and 681C for 90 s, for a total of 10 cycles; 941C for 30 s, 601C for 30 s, and 681C for 90 s þ 5 additional seconds at each cycle, for a total of 25 cycles; and final extension step at 681C for 7 min. The resulting amplicons were then amplified using Taq polymerase, Q solution (Qiagen) and nested primers located in exons 3 and 5, respectively (forward 5 0 -GTGCTGGGATTACAGGCGTGAGTCAC-3 0 and reverse 5 0 -GTGAACGAGCTCTACTGCAGGCTGCAG-3 0 ). Cycling conditions were 951C for 5 min followed by 35 cycles at 951C for 30 s, 601C for 45 s, 721C for 90 s, and a final extension step at 721C for 7 min. As a control, we amplified, as described above, total RNA with primers specific for b-actin (forward 5 0 -CCAAGGC-CAACCGCGAGAAGATGAC-3 0 and reverse 5 0 -AGGGTACATG GTGGTGCCGCCAGAC-3 0 ).
Statistical analysis of linkage data Linkage analysis was performed using either the SuperLink package software (http:// bioinfo.cs.technion.ac.il/superlink/) (Fishelson and Geiger, 2002) or the HOMOZ software (http://www.rfcgr.mrc.ac.uk/Registered/Option/homoz.html) (Kruglyak et al, 1995) . The disease trait was modeled as autosomal recessive, fully penetrant, with no interference and with an allele frequency of 0.0001. Allele frequencies for all (known and newly developed) markers were calculated from a pool of 20 DNA samples obtained from population-matched unrelated healthy individuals.
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Figure 4
Chromosomal map of the new congenital recessive ichthyoses locus. The relative position of selected polymorphic markers and genes is shown according to Mapviewer. Distances in centiMorgan indicate distance from markers to the telomeric end of the chromosome p-arm. The disease interval defined by haplotype analysis is marked in red. 
